| For: | Vasti C, Hertig CM. Neuregulin-1/erbB activities with focus on the susceptibility of the heart to anthracyclines. World J Cardiol 2014; 6(7): 653-662 [PMID: 25068025 DOI: 10.4330/wjc.v6.i7.653] |
|---|---|
| URL: | https://www.wjgnet.com/1949-8462/full/v6/i7/653.htm |
| Number | Citing Articles |
| 1 |
Francesca De luliis, Gerardo Salerno, Ludovica Taglieri, Rosina Lanza, Patrizia Cardelli, Susanna Scarpa. Circulating Neuregulin-1 and Galectin-3 can be Prognostic Markers in Breast Cancer. The International Journal of Biological Markers 2017; 32(3) doi: 10.5301/ijbm.5000262
|
| 2 |
Miguel Anjos, Marta Fontes-Oliveira, Vera M. Costa, Mário Santos, Rita Ferreira. An update of the molecular mechanisms underlying doxorubicin plus trastuzumab induced cardiotoxicity. Life Sciences 2021; 280 doi: 10.1016/j.lfs.2021.119760
|
| 3 |
Song Jie, Guo Wenying, Sun Lebo, Vivek Pandey. Dehydroevodiamine Alleviates Doxorubicin‐Induced Cardiomyocyte Injury by Regulating Neuregulin‐1/ErbB Signaling. Cardiovascular Therapeutics 2024; 2024(1) doi: 10.1155/cdr/5538740
|
| 4 |
|
| 5 |
Andrew Geissler, Sergey Ryzhov, Douglas B. Sawyer. Neuregulins: protective and reparative growth factors in multiple forms of cardiovascular disease. Clinical Science 2020; 134(19) doi: 10.1042/CS20200230
|
| 6 |
Marco Bruno Morelli, Chiara Bongiovanni, Silvia Da Pra, Carmen Miano, Francesca Sacchi, Mattia Lauriola, Gabriele D’Uva. Cardiotoxicity of Anticancer Drugs: Molecular Mechanisms and Strategies for Cardioprotection. Frontiers in Cardiovascular Medicine 2022; 9 doi: 10.3389/fcvm.2022.847012
|
| 7 |
Paul J. Hanson, Al Rohet Hossain, Ye Qiu, Huifang M. Zhang, Guangze Zhao, Cheng Li, Veena Lin, Saheedat Sulaimon, Marli Vlok, Gabriel Fung, Victoria H. Chen, Eric Jan, Bruce M. McManus, David J. Granville, Decheng Yang. Cleavage and Sub-Cellular Redistribution of Nuclear Pore Protein 98 by Coxsackievirus B3 Protease 2A Impairs Cardioprotection. Frontiers in Cellular and Infection Microbiology 2019; 9 doi: 10.3389/fcimb.2019.00265
|
| 8 |
Iva Minga, Hena Patel, Tochi M. Okwuosa, Niti R. Aggarwal. Sex Differences in Cardiac Diseases. 2021; doi: 10.1016/B978-0-12-819369-3.00028-9
|
| 9 |
Syndi Barish, Kathryn Berg, Jeffrey Drozd, Isabella Berglund-Brown, Labeeqa Khizir, Lauren K. Wasson, Christine E. Seidman, Jonathan G. Seidman, Sidi Chen, Martina Brueckner. The H2Bub1-deposition complex is required for human and mouse cardiogenesis. Development 2023; 150(23) doi: 10.1242/dev.201899
|
| 10 |
Trevi R. Mancilla, Brian Iskra, Gregory J. Aune. Comprehensive Physiology. 2019; doi: 10.1002/cphy.c180017
|
| 11 |
Joshua A. Cowgill, Sanjeev A. Francis, Douglas B. Sawyer. Anthracycline and Peripartum Cardiomyopathies. Circulation Research 2019; 124(11) doi: 10.1161/CIRCRESAHA.119.313577
|
| 12 |
Cassady E. Rupert, Kareen L.K. Coulombe. The Roles of Neuregulin-1 in Cardiac Development, Homeostasis, and Disease. Biomarker Insights 2015; doi: 10.4137/BMI.S20061
|
| 13 |
Joshua H. Decker, Radhakrishna Sura, Paul W. Snyder. Toxicologic Pathology for Non-Pathologists. 2019; doi: 10.1007/978-1-4939-9777-0_8
|
| 14 |
Ashot Avagimyan, Rosalinda Madonna, Mohammad Sheibani, Nana Pogosova, Artem Trofimenko, Olga Urazova, Laura Iop, Zinaida Jndoyan, Hasmik Yeranosyan, Anahit Aznauryan, Karmen Sahakyan, Anna Petrosyan, Ruzanna Petrosyan, Marina Tatoyan, Gayane Mkrtchyan, Elina Sulemaniayants, Goarik Meltonyan, Aleh Kuzniatsou, Rupak Mukherjee, Aysa Rezabakhsh, George Koliakos, Giulia Ottaviani, Giuseppe-Biondi Zoccai, Nizal Sarrafzadegan. Translational aspects of doxorubicin-induced cardiotoxicity: What we have omitted for the past decades?. Vascular Pharmacology 2025; 160 doi: 10.1016/j.vph.2025.107526
|
| 15 |
. 2018; doi: 10.70675/60233729z991bz44c3z8c1az8f11484cbb5a
|
| 16 |
Tatiana Ammosova, Kareem Washington, Jamie Rotimi, Namita Kumari, Kahli Smith, Xiaomei Niu, Marina Jerebtsova, Sergei Nekhai. Protein Phosphatase-1 Regulates Expression of Neuregulin-1. Biology 2016; 5(4) doi: 10.3390/biology5040049
|
| 17 |
Megan Goins, Katie Lovell, Greyson Keel, Julia Cook, Robert Lust. Novel Pathogenesis and Treatments for Cardiovascular Disease. 2023; doi: 10.5772/intechopen.105040
|
| 18 |
Yosuke K. Kurokawa, Steven C. George. Tissue engineering the cardiac microenvironment: Multicellular microphysiological systems for drug screening. Advanced Drug Delivery Reviews 2016; 96 doi: 10.1016/j.addr.2015.07.004
|
| 19 |
Toufik Abdul-Rahman, Alden Dunham, Helen Huang, Syed Muhammad Awais Bukhari, Aashna Mehta, Wireko A. Awuah, Deba Ede-Imafidon, Emiliano Cantu-Herrera, Suprateeka Talukder, Amogh Joshi, Deborah W. Sundlof, Rahul Gupta. Chemotherapy Induced Cardiotoxicity: A State of the Art Review on General Mechanisms, Prevention, Treatment and Recent Advances in Novel Therapeutics. Current Problems in Cardiology 2023; 48(4) doi: 10.1016/j.cpcardiol.2023.101591
|
| 20 |
. 2017; doi: 10.70675/805c70a2zb9e2z4b7cz8d3eza7fbf3a82adc
|
| 21 |
Trevi R. Mancilla, Brian Iskra, Gregory J. Aune. Doxorubicin‐Induced Cardiomyopathy in Children. Comprehensive Physiology 2019; 9(3) doi: 10.1002/j.2040-4603.2019.tb00082.x
|
| 22 |
Alan Garcia, Abdul Mueez Alam Kayani, Daniel Alejandro Navarro-Martinez, Ricky E. Lemus-Zamora, Richard Salama-Frisbie, Thomas Fretz, Eduardo Tellez-Garcia, Eduardo Aviles, Brijesh Patel. Cardiotoxic Effects of Osimertinib Compared to Other EGFR Inhibitors: A Systematic Review and Meta-Analysis. Cardiovascular Toxicology 2026; 26(3) doi: 10.1007/s12012-026-10106-x
|
| 23 |
Ahmed M. Kabel, Samir A. Salama, Almokhtar A. Adwas, Remon S. Estfanous. Targeting Oxidative Stress, NLRP3 Inflammasome, and Autophagy by Fraxetin to Combat Doxorubicin-Induced Cardiotoxicity. Pharmaceuticals 2021; 14(11) doi: 10.3390/ph14111188
|
| 24 |
Santiago Cerrizuela, Guillermo A. Vega‐Lopez, Manuel J. Aybar. The role of teratogens in neural crest development. Birth Defects Research 2020; 112(8) doi: 10.1002/bdr2.1644
|
| 25 |
Younan Samuel, Aswin Babu, Foteini Karagkouni, Ayden Ismail, Sunyoung Choi, Stergios Boussios. Cardiac Toxicities in Oncology: Elucidating the Dark Box in the Era of Precision Medicine. Current Issues in Molecular Biology 2023; 45(10) doi: 10.3390/cimb45100526
|